NCT/Study#
NCT05715229 /
G360-IIT
A Multi-Center Phase II Randomized Trial of Immunotherapy versus Chemoimmunotherapy Guided by Circulating Tumor DNA Based Molecular Response on Patients with Metastatic NSCLC
DISEASE GROUP:
Thoracic (Lung)
current phase:
Phase II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
